Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PEPG is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
25 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 4
71 filers reported a long position in PEPG for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $36.1M | 20.1M | Unchanged |
| Commodore Capital LP | $8.1M | 4.5M | Unchanged |
| VIKING GLOBAL INVESTORS LP | $6.3M | 3.5M | Unchanged |
| Laurion Capital Management LP | $5M | 2.8M | Unchanged |
| ADAR1 Capital Management, LLC | $4.7M | 2.6M | +61.2% |
| Vivo Capital, LLC | $4.2M | 2.3M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.5M | 1.9M | -0.1% |
| MILLENNIUM MANAGEMENT LLC | $3.2M | 1.8M | -14.1% |
| RENAISSANCE TECHNOLOGIES LLC | $2.7M | 1.5M | +2,576.5% |
| BlackRock, Inc. | $2.3M | 1.3M | +2.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.